Has Mary McDaniel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,624 in general payments to Mary McDaniel, MD across 186 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mary McDaniel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mary McDaniel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mary McDaniel, MD

Dermatology · de Pere, WINPI 1184015984

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 186 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations.

$3,624in general payments, 2019–2025

Across 186 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$777
Regeneron Healthcare Solutions, Inc.$477
Pfizer$441
Novartis$336
Lilly USA, LLC$229
Incyte Corporation$193
plus $1K from 15 others

What the payments were for

Food & beverage$3,606100%
Education$180%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	54	$777
Regeneron Healthcare Solutions, Inc.	12	$477
Pfizer	39	$441
Novartis	16	$336
Lilly USA, LLC	10	$229
Incyte Corporation	6	$193
Amgen	7	$158
Johnson & Johnson	8	$154
UCB, Inc.	5	$143
Sanofi	6	$115
Boehringer Ingelheim	1	$112
Organon	7	$94
Biofrontera Inc.	1	$85
Galderma Laboratories, L.p.	3	$74
Sun Pharmaceutical Industries Inc.	3	$67
E.r. Squibb & Sons, L.L.C.	3	$57
Revance Therapeutics, Inc.	1	$39
Organogenesis Inc.	1	$23
Dermavant Sciences, Inc.	1	$21
Kyowa Kirin, Inc.	1	$17
Arcutis Biotherapeutics, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,624 in reported general payments places this provider in the 80th percentile of 260 dermatology providers in Wisconsin.

See all dermatology providers in Wisconsin →

Medicare billing

Part B allowed, 2024

$154,189

Medicare patients

494

Services billed

2,013

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cosentyx Unoready PenSecukinumab	16	$122,947
Clobetasol Propionate	84	$3,046
Doxycycline Monohydrate	93	$2,656
Ketoconazole	143	$1,752
Metronidazole	28	$1,751
Fluorouracil	17	$1,084
Mometasone Furoate	68	$970
Mupirocin	136	$890
Triamcinolone Acetonide	110	$750
Betamethasone Dipropionate	15	$632
Fluocinolone Acetonide	12	$577
ValacyclovirValacyclovir Hcl	17	$533
Finasteride	16	$211
Hydrocortisone	27	$183
Minocycline Hcl	13	$166

Paid to pharmacies, not to this prescriber.

Other dermatology in de Pere

Lisa Campbellde Pere$4K
David NelsenJanesville$1.1M
Gabriela MaloneyOconomowoc$725K
Kenneth GordonWauwatosa$577K
Ashley DietrichMilwaukee$466K
Martin OkunFort Atkinson$232K
Betsy WernliManitowoc$177K
Daniel OpelSheboygan$118K
Stephen LewellisPlover$73K
Patrick SafoStevens Point$53K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →